Clinical Trial Update: Safety and Preliminary Efficacy Study of EE001 in Health/Patients Adults with Mild, Moderate, or Severe (NYHA II-IV) Cardiac Insufficiency [EARLY_Phase 1]

View source ↗

Summary

This early-phase trial reports safety and preliminary efficacy data for EE001 in adults with heart failure (cardiac insufficiency); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• EE001

Snippet

Sponsor: Anhui HygeianCells BioMedical Co., Ltd. | Conditions: Cardiac Insufficiency | EARLY_Phase 1 | Status: COMPLETED